These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8133107)

  • 1. Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group.
    Ward RL; Bernstein DI
    J Infect Dis; 1994 Apr; 169(4):900-4. PubMed ID: 8133107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y; Kapikian AZ
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effectiveness of natural rotavirus infection in an American Indian population.
    Moulton LH; Staat MA; Santosham M; Ward RL
    J Infect Dis; 1998 Dec; 178(6):1562-6. PubMed ID: 9815204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological and serological aspects of immune resistance to rotavirus gastroenteritis.
    Chiba S; Nakata S; Ukae S; Adachi N
    Clin Infect Dis; 1993 Mar; 16 Suppl 2():S117-21. PubMed ID: 8384012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.
    Ward RL; Bernstein DI
    Vaccine; 1995 Sep; 13(13):1226-32. PubMed ID: 8578808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field trial of rhesus rotavirus vaccine in infants.
    Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
    Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus infections and their prevention by vaccination.
    Vesikari T
    Antiviral Res; 1985; Suppl 1():293-300. PubMed ID: 3002263
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
    Lanata CF; Black RE; del Aguila R; Gil A; Verastegui H; Gerna G; Flores J; Kapikian AZ; Andre FE
    J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency of serotype G rotavirus isolated from children with diarrhea in Mérida, Yucatán, Mexico].
    González-Losa MR; Puerto-Solís M; Polanco-Marín GG; Peniche-Rodríguez R; Puerto FI
    Rev Invest Clin; 1994; 46(3):215-9. PubMed ID: 7973145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
    Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
    N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from rotavirus reinfection: 2-year prospective study.
    Bernstein DI; Sander DS; Smith VE; Schiff GM; Ward RL
    J Infect Dis; 1991 Aug; 164(2):277-83. PubMed ID: 1649875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody.
    Ward RL; Clemens JD; Knowlton DR; Rao MR; van Loon FP; Huda N; Ahmed F; Schiff GM; Sack DA
    J Infect Dis; 1992 Dec; 166(6):1251-7. PubMed ID: 1331249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.
    Clark HF; Borian FE; Bell LM; Modesto K; Gouvea V; Plotkin SA
    J Infect Dis; 1988 Sep; 158(3):570-87. PubMed ID: 2842405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.
    Bernstein DI; Smith VE; Sander DS; Pax KA; Schiff GM; Ward RL
    J Infect Dis; 1990 Nov; 162(5):1055-62. PubMed ID: 2172394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of natural rotavirus infection.
    Velázquez FR
    Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S54-6. PubMed ID: 19252424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroepidemiology of human rotaviruses in a community of the Avellaneda district, Province of Buenos Aires].
    Gómez J; Bercovich A; Alvarez A; Garrido D; Grinstein S
    Rev Argent Microbiol; 1990; 22(4):182-91. PubMed ID: 1966501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-rotavirus vaccinations].
    Schmitz J
    Arch Pediatr; 1999 Sep; 6(9):979-84. PubMed ID: 10519034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.